|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-12-30
|
|
pubmed:abstractText |
A frameshift mutation is present in one allele of the Atf4 gene in genomic DNA from F9 embryonal carcinoma stem cells. The mutation results in the fusion of a short 5' open reading frame to the coding sequence of Atf4, replacing the first 18 N-terminal amino acids with 50 amino acids encoded by the upstream open reading frame. The ability of both normal and mutated Atf4 gene products to influence cell growth was tested using an NIH3T3 cell transformation assay. Overexpression of mutant Atf4 suppresses ras-induced transformation in this assay. In G418r cell lines derived from parallel co-transfections, expression of transfected mutant Atf4 mRNA correlates with a loss of transformed morphology and a reduction in ras mRNA levels. Transient cotransfection assays in NIH3T3 cells demonstrate that wild type Atf4 is able to inhibit transcription directed by the human c-Ha-ras1 promoter and that this effect is increased by the mutation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ATF4 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Activating Transcription Factor 4,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/HRAS protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins p21(ras),
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0006-291X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
12
|
|
pubmed:volume |
228
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
586-95
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8920955-3T3 Cells,
pubmed-meshheading:8920955-Activating Transcription Factor 4,
pubmed-meshheading:8920955-Amino Acid Sequence,
pubmed-meshheading:8920955-Animals,
pubmed-meshheading:8920955-Base Sequence,
pubmed-meshheading:8920955-Carcinoma, Embryonal,
pubmed-meshheading:8920955-Cell Line,
pubmed-meshheading:8920955-Cell Transformation, Neoplastic,
pubmed-meshheading:8920955-DNA Primers,
pubmed-meshheading:8920955-Frameshift Mutation,
pubmed-meshheading:8920955-Genes, ras,
pubmed-meshheading:8920955-Humans,
pubmed-meshheading:8920955-Kinetics,
pubmed-meshheading:8920955-Mice,
pubmed-meshheading:8920955-Molecular Sequence Data,
pubmed-meshheading:8920955-Open Reading Frames,
pubmed-meshheading:8920955-Polymerase Chain Reaction,
pubmed-meshheading:8920955-Proto-Oncogene Proteins p21(ras),
pubmed-meshheading:8920955-RNA, Messenger,
pubmed-meshheading:8920955-Recombinant Proteins,
pubmed-meshheading:8920955-Transcription, Genetic,
pubmed-meshheading:8920955-Transcription Factors,
pubmed-meshheading:8920955-Transfection
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Mutated Atf4 suppresses c-Ha-ras oncogene transcript levels and cellular transformation in NIH3T3 fibroblasts.
|
|
pubmed:affiliation |
Department of Molecular and Cellular Biology, Roswell Park Cancer Center, Buffalo, New York 14263, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
